Crossmark

https://doi.org/10.1016/j.abdp.2024.10.002

Crossref DOI link: https://doi.org/10.1016/j.abdp.2024.10.002

Published Print: 2000

Update policy: https://doi.org/10.1016/elsevier_cm_policy

License Information

Text and Data Mining valid from 2000-01-01

Text and Data Mining valid from 2000-01-01

Version of Record valid from 2024-10-20
More Information

This article is maintained by: Elsevier

Article Title: Comparação da eficácia em longo prazo e da relação custo‐eficácia de omalizumabe nas doses de 150mg e 300mg em pacientes com urticária crônica espontânea

Journal Title: Anais Brasileiros de Dermatologia (Versão em Português)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.abdp.2024.10.002

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.abd.2024.02.006

Content Type: article

Copyright: © 2024 Sociedade Brasileira de Dermatologia. Published by Elsevier España, S.L.U.